Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-617,755
Closed -$48.2M 47
2020
Q4
$48.2M Buy
617,755
+129,129
+26% +$9.88M 3.68% 11
2020
Q3
$38.7M Buy
+488,626
New +$38.3M 3.09% 13
2017
Q4
Sell
-825,297
Closed -$50.4M 36
2017
Q3
$50.4M Sell
825,297
-4,613
-0.6% -$280K 3.02% 17
2017
Q2
$50.8M Buy
+829,910
New +$50.5M 2.9% 19
2017
Q1
Sell
-905,861
Closed -$50.9M 39
2016
Q4
$50.9M Buy
+905,861
New +$53M 3.54% 14
2014
Q2
Sell
-1,021,800
Closed -$55.4M 43
2014
Q1
$55.4M Buy
+1,021,800
New +$52.9M 3.7% 8

Other funds holding MRK

Bridger Management's MRK Position: Q1 2021 in Review

Bridger Management sold out of Merck (MRK) in Q1 2021, closing a stake of 617,755 shares — an estimated $48.2M sold.

Bridger Management first reported a position in MRK in Q1 2014 and held it in 6 quarters. The position peaked at $55.4M in Q1 2014. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Bridger Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Bridger Management sold 617,755 Merck shares in Q1 2021, an estimated $48.2M.
  • Bridger Management first reported a position in Merck in Q1 2014 and held it in 6 quarters.
  • Bridger Management's Merck position peaked at $55.4M in Q1 2014.
  • 2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Bridger Management's 13F filing for Q1 2021, filed 14 May 2021.